APA citiranje

Leng, H., & Simon, K. (2019). Translational potential of a novel osteoclast inhibitor, eliglustat, in myeloma bone disease.

Chicago Style (17th ed.) Citation

Leng, H., and K. Simon. Translational Potential of a Novel Osteoclast Inhibitor, Eliglustat, in Myeloma Bone Disease. 2019.

MLA citiranje

Leng, H., and K. Simon. Translational Potential of a Novel Osteoclast Inhibitor, Eliglustat, in Myeloma Bone Disease. 2019.